Searched for
RAJEEV JUNEJA
Mankind Pharma’s Rx for success: Aatmanirbhar push, affordable careMankind Pharma, guided by Ramesh and Rajeev Juneja, is a leading Indian pharmaceutical firm. The company focuses on mass-market drugs and h...
PHDCCI urges RBI to boost MSME credit, fix LoC rulesThe PHD Chamber of Commerce and Industry has approached the Reserve Bank of India. They are seeking increased credit for small businesses. ...
Mankind Pharma targets early Semaglutide launchMankind Pharma is set to enter India's semaglutide market soon. The drug's patent expires this month, opening doors for new players. Mankin...
Complete Circle Capital secures $3 million in funding from Mankind Pharma promotersComplete Circle Capital raised $3 million in its first funding round, led by Mankind Pharma’s promoter family. Funds will drive AI-powered ...
Mankind: How Meerut brothers built India's 4th largest pharma firmMankind Pharma has announced a significant move by acquiring Bharat Serums and Vaccines Ltd for Rs 13,630 crore. The acquisition, partly fu...
Mankind can clear debt taken for BSV buy in 3 years: MD Rajeev JunejaMankind Pharma aims to clear its ₹13,630-crore debt from acquiring Bharat Serums and Vaccines within three years, according to MD Rajeev Ju...
Mankind Pharma scouts for M&A deals to boost local branded bizMankind Pharma, the fourth-largest pharmaceutical company in India, led by Rajeev Juneja, is seeking mergers, acquisitions, and in-licensin...
Resilience and ambition have got us to where we are today, say Mankind’s Juneja brothersIntroducing pocket-friendly medicines in a price-sensitive market like India was a revolutionary strategy that made a big difference. "It t...
ETMarkets Management Talk | Mankind Pharma MD explains 2 reasons behind drop in marginsMankind Pharma's gross margin fell due to inventory accruals and production capacity issues. Revenue growth driven by domestic business and...
ET Awards for Corporate Excellence: Rx Meerut: Mankind Pharma's bottom-up journey to the leader boardThe company has for the last five years been ranked number one in the number of prescriptions. Manforce condoms, oral contraceptives Prega ...
Mankind Q1 Results: Net profit zooms 66% YoY to Rs 494 croreThe Delhi-headquartered drugmaker posted Rs 298 crore in the corresponding quarter of the previous year. Revenue rose 18% YoY to Rs 2579 cr...
Why Mankind has an edge over its peers? Rajeev Juneja explainsIn 95, our turnover was Rs 5 crore and every year, the thought was, whatever we are doing in one year, can we do in one month? On this phil...
Mankind Pharma announces IPO price band at Rs 1,026-1,080At the upper end of the price band, the fourth largest pharmaceutical company in terms of domestic sales will be valued at ₹43,264 crore. T...
Mankind setting up Rs 300-crore unit to manufacture fertility hormoneMankind is investing about ₹250-₹300 crore on the Udaipur unit that is expected to begin operations by September-October this year. The uni...
Mankind Pharma enters pet care segment with launch PetStar brandMankind said the brand aims to build and support the pet care ecosystem by offering pet food, medicine, supplements, and grooming products.
Mankind Pharma acquires majority stake in Upakarma Ayurveda"As Mankind Pharma works towards improving the healthcare of people, we have associated with Upakarma Ayurveda in order to cater to the eme...
Mankind Pharma to donate Rs 100 cr to families of deceased frontline COVID warriorsThe company plans to start releasing the money with immediate effect and hopes to complete it within three months, Mankind Pharma said in a...
SoftBank’s arm may open Mumbai officeThe Japanese investment giant has also roped in Sumer Juneja from venture capital firm Norwest Venture Partners to lead Indian operations.
The story of Juneja siblings, the biggest disruptors in Indian pharma spaceThese former medical representatives have consistently struck gold at the bottom of the pyramid, selling drugs everywhere, priced lower tha...
Who are India's richest people? Find out here...Mukesh Ambani, retained the richest Indian title for the sixth year running.